Trim6 depletion in immunologically ‘cold’ MSS gastric cancer cells promotes CD8+ T-cell infiltration by activating the cGAS-mediated innate immune response and sensitizes these tumors to anti-PD-1/PD-L1 treatment. Here, TRIM6 is linked to gastric cancer.